39P AntiEGFR-based maintenance versus stop&go strategy in patients with left-sided, non MSI, RAS/BRAF wild type (wt) metastatic colorectal cancer (mCRC): Individual patient data (IPD) pooled analysis of randomized clinical trials (RCTs). - Raimondi, A.; Tinè, G.; De Stefano, A.; Ballhausen, A.; Bouche, O.; Morano, F.; Stahler, A.; Romano, C.; Prisciandaro, M.; Randon, G.; Gourgou, S.; Alig, A.H.S.; et al. (Annals of Oncology, 2025)